News | May 10, 2023
Cigniti bags ‘Best IoT Healthcare Platform’ award in 2023
The Awards recognizes standout digital health & medical technology products and companies
The Awards recognizes standout digital health & medical technology products and companies
Brexit had a negative impact on NHS staff shortages and worsened the workforce crisis
Q4 results was challenging driven by steep fall in CDMO revenues and higher upfront cost of Capex projects and R&D projects
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
Everest and SPH Kyuan will work closely to promote import and channel distribution of XERAVA in China
Acceptance based on results from the Phase 3 KEYNOTE-859 trial, which showed significant overall survival benefit in these patients with HER2-negative disease, regardless of PD-L1 expression
NGS enables researchers to quickly sequence entire genomes and transcriptomes of organisms.
Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers
The safety profile of LAGEVRIO in this trial was generally consistent with that observed in previously reported clinical studies
Zidavi is recommended by the Infectious Disease Society of America
Subscribe To Our Newsletter & Stay Updated
